LivaNova Plc is a global medical technology company that develops therapeutic solutions across three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. Their products include heart-lung machines, neuromodulation devices, and life support systems.
LivaNova PLC (LIVN) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, LivaNova PLC's actual EPS was $1.05, beating the estimate of $0.87 per share, resulting in a 20.32% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
